Wells Fargo’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $144M | Buy |
854,345
+97,919
| +13% | +$16.7M | 0.03% | 505 |
|
|
2025
Q4 | $128M | Buy |
756,426
+181,345
| +32% | +$29.5M | 0.02% | 535 |
|
|
2025
Q3 | $83M | Sell |
575,081
-103,425
| -15% | -$14.1M | 0.02% | 678 |
|
|
2025
Q2 | $85.8M | Sell |
678,506
-205,622
| -23% | -$25.2M | 0.02% | 634 |
|
|
2025
Q1 | $113M | Buy |
884,128
+204,332
| +30% | +$27.7M | 0.03% | 494 |
|
|
2024
Q4 | $89.9M | Sell |
679,796
-103,550
| -13% | -$14.6M | 0.02% | 568 |
|
|
2024
Q3 | $114M | Buy |
783,346
+89,265
| +13% | +$12.9M | 0.03% | 494 |
|
|
2024
Q2 | $95.3M | Buy |
694,081
+39,679
| +6% | +$5.3M | 0.02% | 515 |
|
|
2024
Q1 | $89.8M | Sell |
654,402
-10,014
| -2% | -$1.37M | 0.02% | 540 |
|
|
2023
Q4 | $90.3M | Sell |
664,416
-8,910
| -1% | -$1.09M | 0.02% | 503 |
|
|
2023
Q3 | $82.3M | Sell |
673,326
-18,042
| -3% | -$2.29M | 0.02% | 499 |
|
|
2023
Q2 | $87.8M | Sell |
691,368
-49,524
| -7% | -$6.43M | 0.02% | 493 |
|
|
2023
Q1 | $95.7M | Sell |
740,892
-159,204
| -18% | -$20.8M | 0.03% | 449 |
|
|
2022
Q4 | $118M | Buy |
900,096
+89,307
| +11% | +$11.5M | 0.04% | 383 |
|
|
2022
Q3 | $94.8M | Buy |
810,789
+131,105
| +19% | +$16.3M | 0.03% | 413 |
|
|
2022
Q2 | $80M | Sell |
679,684
-33,441
| -5% | -$3.97M | 0.02% | 495 |
|
|
2022
Q1 | $92.9M | Buy |
713,125
+1,227
| +0.2% | +$160K | 0.02% | 514 |
|
|
2021
Q4 | $109M | Buy |
711,898
+29,734
| +4% | +$4.6M | 0.03% | 459 |
|
|
2021
Q3 | $110M | Sell |
682,164
-14,463
| -2% | -$2.43M | 0.02% | 613 |
|
|
2021
Q2 | $114M | Buy |
696,627
+4,143
| +0.6% | +$638K | 0.03% | 615 |
|
|
2021
Q1 | $104M | Sell |
692,484
-8,488
| -1% | -$1.35M | 0.02% | 651 |
|
|
2020
Q4 | $106M | Sell |
700,972
-62,811
| -8% | -$8.98M | 0.03% | 613 |
|
|
2020
Q3 | $103M | Sell |
763,783
-59,605
| -7% | -$8.09M | 0.03% | 553 |
|
|
2020
Q2 | $113M | Buy |
823,388
+232,298
| +39% | +$29.6M | 0.03% | 492 |
|
|
2020
Q1 | $63.7M | Buy |
591,090
+6,263
| +1% | +$721K | 0.02% | 652 |
|
|
2019
Q4 | $70.5M | Sell |
584,827
-22,711
| -4% | -$2.53M | 0.02% | 755 |
|
|
2019
Q3 | $60.5M | Buy |
607,538
+20,554
| +4% | +$2.15M | 0.02% | 799 |
|
|
2019
Q2 | $64M | Sell |
586,984
-84,318
| -13% | -$8.97M | 0.02% | 798 |
|
|
2019
Q1 | $75.1M | Sell |
671,302
-206,109
| -23% | -$22.6M | 0.02% | 688 |
|
|
2018
Q4 | $84.6M | Buy |
877,411
+108,432
| +14% | +$11.5M | 0.03% | 579 |
|
|
2018
Q3 | $93.8M | Sell |
768,979
-47,594
| -6% | -$5.6M | 0.03% | 615 |
|
|
2018
Q2 | $89.7M | Sell |
816,573
-34,500
| -4% | -$3.69M | 0.03% | 611 |
|
|
2018
Q1 | $90.8M | Sell |
851,073
-4,281
| -0.5% | -$475K | 0.03% | 605 |
|
|
2017
Q4 | $91.3M | Sell |
855,354
-23,184
| -3% | -$2.48M | 0.03% | 612 |
|
|
2017
Q3 | $97.7M | Buy |
878,538
+33,918
| +4% | +$3.63M | 0.03% | 558 |
|
|
2017
Q2 | $87.3M | Buy |
844,620
+35,130
| +4% | +$3.46M | 0.03% | 597 |
|
|
2017
Q1 | $79.1M | Buy |
809,490
+78,294
| +11% | +$7.5M | 0.03% | 643 |
|
|
2016
Q4 | $64.7M | Buy |
731,196
+124,389
| +20% | +$11.3M | 0.02% | 697 |
|
|
2016
Q3 | $58.5M | Buy |
606,807
+95,319
| +19% | +$9.07M | 0.02% | 716 |
|
|
2016
Q2 | $43.9M | Buy |
511,488
+133,125
| +35% | +$11.9M | 0.02% | 826 |
|
|
2016
Q1 | $32.9M | Sell |
378,363
-1,062,633
| -74% | -$95M | 0.01% | 984 |
|
|
2015
Q4 | $163M | Buy |
1,440,996
+728,295
| +102% | +$79M | 0.06% | 330 |
|
|
2015
Q3 | $72.1M | Buy |
712,701
+96,117
| +16% | +$11.5M | 0.03% | 586 |
|
|
2015
Q2 | $75.8M | Buy |
616,584
+28,659
| +5% | +$3.43M | 0.03% | 622 |
|
|
2015
Q1 | $67.3M | Sell |
587,925
-101,937
| -15% | -$11.2M | 0.03% | 647 |
|
|
2014
Q4 | $69.8M | Buy |
689,862
+108,240
| +19% | +$10.5M | 0.03% | 612 |
|
|
2014
Q3 | $53M | Sell |
581,622
-9,651
| -2% | -$847K | 0.02% | 715 |
|
|
2014
Q2 | $50.7M | Sell |
591,273
-40,344
| -6% | -$3.18M | 0.02% | 765 |
|
|
2014
Q1 | $49.7M | Buy |
631,617
+36,180
| +6% | +$3.01M | 0.02% | 761 |
|
|
2013
Q4 | $45.1M | Sell |
595,437
-2,169
| -0.4% | -$154K | 0.02% | 798 |
|
|
2013
Q3 | $41.8M | Buy |
597,606
+21,312
| +4% | +$1.4M | 0.02% | 774 |
|
|
2013
Q2 | $33.4M | Buy |
+576,294
| New | +$33.3M | 0.02% | 841 |
|
Other funds holding IBB
CB
Wells Fargo's IBB Position: Q1 2026 in Review
Wells Fargo increased its iShares Biotechnology ETF (IBB) stake by 13% in Q1 2026, buying an estimated $16.7M and bringing the position to 854,345 shares worth $144M. The position accounts for 0.03% of the portfolio, ranked #505.
Wells Fargo first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $163M in Q4 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Wells Fargo held 854,345 shares of iShares Biotechnology ETF worth $144M as of Q1 2026.
- Wells Fargo bought 97,919 iShares Biotechnology ETF shares in Q1 2026, an estimated $16.7M.
- iShares Biotechnology ETF made up 0.03% of Wells Fargo's portfolio in Q1 2026, its #505 holding.
- Wells Fargo first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's iShares Biotechnology ETF position peaked at $163M in Q4 2015.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.